UOC
BCYC

UBS O'Connor’s Bicycle Therapeutics BCYC Stock Holding History

UBS O'Connor’s Portfolio BCYC Stock Details BCYC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-50,000
Closed -$11.3K – 301
2025
Q2 		$11.3K Buy
+50,000
New +$398K ﹤0.01% 349
2024
Q4 		– Sell
-20,000
Closed -$10.5K – 443
2024
Q3 		$10.5K Buy
+20,000
New +$461K ﹤0.01% 462
2024
Q2 		– Sell
-70,000
Closed -$130K – 552
2024
Q1 		$130K Sell
70,000
-55,000
-44% -$1.17M ﹤0.01% 415
2023
Q4 		$226K Buy
125,000
+101,500
+432% +$1.68M 0.01% 396
2023
Q3 		$52.3K Buy
+23,500
New +$537K ﹤0.01% 487

Other funds holding BCYC

BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
FIS
FCPM III Services Naarden, Netherlands $722M AUM 73.61% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $3.61B AUM 203.3% 1-Year Est. Return
LFCM
Long Focus Capital Management San Juan, Puerto Rico $3.8B AUM 7.31% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
CS
Candriam SCA Strassen, Luxembourg, Luxembourg $19.3B AUM 39.18% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $187B AUM 18.48% 1-Year Est. Return